BioMarin Pharmaceutical | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
Acadia Pharmaceuticals USD 732.79M 155.61M 2024-12
Agios Pharmaceuticals USD 1.47B 74.43M 2025-03
Alnylam Pharmaceuticals USD 115.43M 48.35M 2025-03
Amgen USD 6.21B 330M 2025-03
Bayer EUR 32.04B 1.49B 2024-12
Biogen USD 16.98B 262.7M 2025-03
BioMarin Pharmaceutical USD 5.79B 135.47M 2025-03
Gilead Sciences USD 19.33B 856M 2024-12
Incyte USD 3.67B 219.94M 2025-03
Insmed USD 285.38M 198.04M 2024-12
Ionis Pharmaceuticals USD 475.73M 112.62M 2025-03
Moderna USD 10.07B 835M 2025-03
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
PTC Therapeutics USD -185760000 912.31M 2025-03
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 77.86B 4.86B 2024-12
Sarepta Therapeutics USD 1.14B 385.02M 2025-03
Ultragenyx Pharmaceutical USD 144.25M 111.05M 2025-03
United Therapeutics USD 6.81B 363.2M 2025-03
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12



BioMarin Pharmaceutical Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.